GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Marpai Inc (NAS:MRAI) » Definitions » Debt-to-Equity

Marpai (Marpai) Debt-to-Equity : -0.31 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Marpai Debt-to-Equity?

Marpai's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.51 Mil. Marpai's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $3.68 Mil. Marpai's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-13.44 Mil. Marpai's debt to equity for the quarter that ended in Dec. 2023 was -0.31.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Marpai's Debt-to-Equity or its related term are showing as below:

MRAI' s Debt-to-Equity Range Over the Past 10 Years
Min: -5.73   Med: -0.31   Max: 0.99
Current: -0.31

During the past 5 years, the highest Debt-to-Equity Ratio of Marpai was 0.99. The lowest was -5.73. And the median was -0.31.

MRAI's Debt-to-Equity is not ranked
in the Healthcare Plans industry.
Industry Median: 0.39 vs MRAI: -0.31

Marpai Debt-to-Equity Historical Data

The historical data trend for Marpai's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marpai Debt-to-Equity Chart

Marpai Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
-5.73 -2.67 0.07 0.99 -0.31

Marpai Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.99 -2.99 -1.78 -0.48 -0.31

Competitive Comparison of Marpai's Debt-to-Equity

For the Healthcare Plans subindustry, Marpai's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marpai's Debt-to-Equity Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Marpai's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Marpai's Debt-to-Equity falls into.



Marpai Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Marpai's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Marpai's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Marpai  (NAS:MRAI) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Marpai Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Marpai's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Marpai (Marpai) Business Description

Traded in Other Exchanges
N/A
Address
5701 East Hillsborough Avenue, Suite 1417, Tampa, FL, USA, 33610-5428
Marpai Inc operates as a health plan company. It uses A.I. to predict and help prevent costly events for its members, and in turn, lower its clients' health care costs. It offers a health plan services system that addresses the problems of healthcare past and enables companies to provide healthcare to employees. The company generates the majority of its revenue from the United States.
Executives
Yaron Eitan director 65 CHALLENGER ROAD, RIDGEFIELD PARK NJ 07660
Damien Lamendola director, 10 percent owner 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Edmundo Gonzalez director, officer: CEO, Secretary and Director C/O SELWAY CAPITAL ACQUISITION CORP., 74 GRAND AVENUE, 2ND FLOOR, ENGLEWOOD NJ 07631
Sagiv Shiv director
Vincent Kane director 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33131
Ronnie Brown officer: Chief Operating Officer 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Mohsen Moazami director C/O ASTREA ACQUISITION CORP., 55 OCEAN LANE DRIVE, APT. 3021, KEY BISCAYNE FL 33149
Lutz Finger officer: See Remarks 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610
Yoram Bibring officer: Chief Financial Officer C/O SELWAY ACQUISITION CORPORATION, 66 FORD ROAD, SUITE 230, DENVILLE NJ 07834
Jane Cavalier director 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Diclaudio Colleen director 456 SEATON STREET, LOS ANGELES CA 90013
Art Hoath officer: Chief Revenue Officer 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Gonen Antebi director 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33610-5428
Eli David other: See footnote (1) 5701 EAST HILLSBOROUGH AVENUE, SUITE 1417, TAMPA FL 33131